" /> Adrenal cancer risk assessment & urine steroid fractions panel:-:-: Patient:-: - CISMeF





Preferred Label : Adrenal cancer risk assessment & urine steroid fractions panel:-:-: Patient:-:;

LOINC status : ACTIVE;

LOINC display name : Adrenal cancer risk assessment and urine steroid fractions panel;

LOINC long common name : Adrenal cancer risk assessment and urine steroid fractions panel;

LOINC short name : Adrenal ca risk assess ur steroid Pnl;

LOINC description : A risk assessment based on patient clinical data combined with biochemical steroid results to assess the probability of a malignant adrenal cortical carcinoma (ACC) or other malignancy (e.g. sarcoma, lymphoma) versus the probability of a benign mass (e.g. adenoma, myelolipoma, cyst). Clinical biomarkers may include age at diagnosis, gender, mode of discovery, hormonal status (e.g. overproduction), tumor diameter, and density of the tumor by CT.;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.